Biosenta Inc.
ZRO
CNSX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2,200.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2,200.00% | 0.00% | |||
| Cost of Revenue | 1,500.00% | 0.00% | |||
| Gross Profit | 600.00% | -- | |||
| SG&A Expenses | 18.66% | -22.66% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.80% | -20.75% | |||
| Operating Income | -14.75% | 20.76% | |||
| Income Before Tax | 11.11% | 7.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.11% | 7.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.11% | 7.81% | |||
| EBIT | -14.75% | 20.76% | |||
| EBITDA | -14.78% | 20.79% | |||
| EPS Basic | 10.77% | 5.11% | |||
| Normalized Basic EPS | 11.11% | 5.81% | |||
| EPS Diluted | 10.77% | 5.11% | |||
| Normalized Diluted EPS | 11.11% | 5.81% | |||
| Average Basic Shares Outstanding | 0.00% | -3.13% | |||
| Average Diluted Shares Outstanding | 0.00% | -3.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||